Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor II-I repeat domain-containing protein 1 (GTF2IRD1) is a multifunctional transcription factor belonging to the TFII-I family. The protein contains five GTF2I-like repeats, each with a potential helix-loop-helix (HLH) motif, which enables interactions with other HLH proteins and DNA. GTF2IRD1 orchestrates complex developmental gene networks, particularly in craniofacial patterning, cognitive development, and social behaviors. Its loss or reduced dosage is strongly implicated in the neurocognitive and craniofacial features of Williams–Beuren syndrome, a disorder caused by deletions at chromosome 7q11.23. GTF2IRD1 plays additional roles in tissue homeostasis, skeletal muscle fiber type specification, and interacts with chromatin to regulate gene expression, including negative autoregulation of its own promoter. Its function is essential for proper embryonic and postnatal development of the central nervous system and peripheral tissues[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor II-I repeat domain-containing protein 1 (GTF2IRD1).